← Open Payments lookup

ROCHELLE RICKMAN: Open Payments

NPI 1457692634 · EVERETT, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,211 in 62 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $17 · 2025 $1,211

Food & beverage: $995Education: $216
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.9$380
Neurocrine BioSciences, Inc.17$219
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$187
Alkermes, Inc.13$142
Otsuka America Pharmaceutical, Inc.3$71
E.R. Squibb & Sons, L.L.C.3$63
Vanda Pharmaceuticals Inc.2$57
Janssen Pharmaceuticals, Inc2$34
Axsome Therapeutics, Inc.1$34
ABBVIE INC.1$24

Products named: INGREZZA, CAPLYTA, ARISTADA, AUSTEDO XR, REXULTI, COBENFY, FANAPT, INVEGA SUSTENNA.

Industry payments across WA — which companies pay providers there.